Diffuse Pleural Thickening

Diffuse pleural thickening (DPT) is a fibrotic condition affecting the visceral pleura — the thin membrane that directly covers the lung surface. Unlike pleural plaques, which form on the parietal pleura (the chest wall lining) and are typically well-defined, DPT involves widespread, continuous thickening that can extend across large areas of the lung surface and may bridge into the underlying lung parenchyma.¹

DPT is one of the most common non-malignant manifestations of asbestos exposure, occurring in an estimated 5-13% of heavily exposed workers. The condition develops when inhaled asbestos fibers reach the pleural space and trigger a chronic inflammatory response that leads to progressive fibrosis of the visceral pleura. Because the thickened membrane restricts lung expansion, patients frequently develop a restrictive ventilatory defect that can significantly impair breathing capacity.²

Distinguishing DPT from malignant mesothelioma is a critical diagnostic challenge. Both conditions involve pleural thickening visible on imaging, but DPT lacks the nodular enhancement, mediastinal pleural involvement, and progressive nature characteristic of mesothelioma. High-resolution CT scanning and, in ambiguous cases, thoracoscopic biopsy are used to differentiate the two conditions. Serial imaging over 6-12 months may be necessary to confirm stability and exclude malignancy.³

From a legal perspective, DPT is recognized as an asbestos-related disease in most jurisdictions and may qualify individuals for compensation through asbestos trust funds, workers' compensation, or personal injury litigation. The presence of DPT also serves as objective medical evidence of significant prior asbestos exposure, which can strengthen related legal claims.⁴

Common Symptoms

• Progressive dyspnea — breathlessness that worsens over months to years as fibrosis restricts lung expansion
• Reduced exercise tolerance — decreased ability to perform physical activities due to impaired gas exchange
• Chest tightness — a sensation of constriction caused by the thickened, inelastic pleura
• Chronic dry cough — non-productive cough triggered by pleural irritation
• Pleuritic chest pain — sharp pain that worsens with deep breathing, particularly in early stages

Symptoms typically develop 15-30 years after initial asbestos exposure and progress gradually. Many patients remain asymptomatic until significant functional impairment has occurred.¹

Asbestos exposure accounts for the majority of DPT cases. Inhaled asbestos fibers migrate to the pleural space, where they provoke a sustained inflammatory reaction. Over years, this chronic inflammation produces progressive fibrosis of the visceral pleura.² Other causes include:

• Prior pleural infection (tuberculosis, empyema)
• Previous hemothorax or chest trauma
• Radiation therapy to the chest
• Drug reactions (ergot derivatives, methysergide)
• Connective tissue diseases (rheumatoid arthritis, lupus)

• Cumulative asbestos dose — higher fiber burden increases risk significantly
• Amphibole fiber type — crocidolite and amosite more fibrogenic than chrysotile
• Duration of exposure — longer exposure periods correlate with greater risk
• Prior benign asbestos pleural effusion — often precedes DPT development
• Occupational setting — shipyard workers, insulators, construction workers at highest risk

Diagnostic Criteria

DPT is diagnosed when imaging demonstrates continuous pleural thickening ≥3 mm extending over ≥25% of the chest wall, with or without blunting of the costophrenic angle. Key diagnostic tools include:³

• High-resolution CT (HRCT) — gold standard for characterizing extent, thickness, and distinguishing from plaques
• Pulmonary function tests — typically show restrictive pattern with reduced FVC and preserved FEV1/FVC ratio
• Chest X-ray — initial screening showing blurred costophrenic angles and pleural opacification
• Thoracoscopic biopsy — reserved for cases where malignancy cannot be excluded by imaging

No curative treatment exists for DPT. Management focuses on symptom control and monitoring:²

• Pulmonary rehabilitation — structured exercise programs to maintain functional capacity
• Bronchodilators — may provide modest symptomatic relief in some patients
• Supplemental oxygen — for patients with significant hypoxemia
• Pleurectomy/decortication — rarely performed; considered only in severe, symptomatic cases
• Smoking cessation — essential to prevent additional pulmonary impairment

DPT is a progressive condition, though the rate of decline varies considerably. Most patients experience a slow reduction in lung function over years. Approximately 10-15% of patients develop significant disability requiring supplemental oxygen. DPT itself does not transform into mesothelioma, but its presence indicates asbestos exposure that independently increases mesothelioma risk.⁴

Prevention centers on eliminating asbestos exposure through occupational safety measures, proper handling of asbestos-containing materials, and adherence to regulatory exposure limits. Workers with known exposure should undergo regular surveillance with chest imaging and pulmonary function testing.¹